chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Headache and achy the next two days. Day three swollen lymph nodes in left armpit for next three weeks. Third week, swollen lymph nodes in both armpits and groin area. Vomiting, nausea , headache and severe fatigue since vaccine and still continues.
pt arrived @ 10AM c/o swelling of lower lip p/flu shot;devel sneezing, cough, lip swelling;no tongue swelling; denied hx egg allergy; denied prior flu vax rxn;
Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Medium, Additional Details: patient reported lip swelling. told to seek medical attention especially if trouble swallowing/breathing. Called pt again 15 min later, patient still responsive and no trouble breathing ect.
Hives since 4/30/2021 first vaccine 3/16/21 and second 4/6/21
A report was received from a health care professional on 9OCT2003 concerning two vaccinees of unknown demography who experienced fever, night sweats, stiff joints and headache on 7OCT2003 after receiving Fluvirin vaccine on 7OCT2003. on 7OCT2003, two vaccinees received Fuvirin and later that evening they both experienced fever of 101-102 degrees Fahrenheit, night sweats, stiff joints and headache. The vaccinees' symptoms improved on 9OCT2003. There was insufficient information to determine the reporter's causality assessment. No follow up pending as the reporter will not collect any further information. Update 1. 17DEC2003.  A follow up report was received form a health care professional concerning a male vaccinee, of unspecified age who experienced fever, night sweats, stiff joints, headache and achiness all over on 7OCT2003 after receiving Fluvirin vaccine on the same day. On 7OCT2003 the vaccine experienced fever, night sweats, stiff joints, headache and achiness all over following Fluvirin vaccination. No follow up pending as the reporter will not collect any further information. Master file. Cross Reference with PJP200400060.
Pt received vax and developed varicella 1 year later in August 1998, per medical doctor.
Broke out with Herpes Simplex all over my face - have had cold sore on lips before but never had global facial simplex on my face - Because lesions are on both sides of my face - shingles was ruled out.   Wish I would have been told that, due to this affecting my immune system, this could happen!!!  This last booster was huge overload to my immune system.  You should see my face - just worried about it getting into my eyes.!! I do look like the antivacinators say could happen.  Very upset that this was not given as warning -
hives, itchy, and burning started 6/12 generalized rash over the entire body including mouth now . Pt was seen in the ER twice 6/13/21 and 6/14/21
pt recvd vax;pm p/ vax had high shrill cry & extreme irritability w/ T 103; Md said pertussis rxn;did not call hlth unit;
Breakthrough case admission after 4 vaccines Pfizer 1/26/21 lot# EL9264;  Pfizer 2/16/21 lot# EN6200;  Pfizer 10/24/21 lot# FF2490;  Pfizer 5/13/22 lot# FK9894
left arm was really sore; could not lift or stretch it without pain for 2 + months; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 69-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 28Jan2022 as dose 3 (booster), single (Lot number: FL3198) at the age of 69 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Diabetes2" (unspecified if ongoing), notes: Diabetes2; "COPD" (unspecified if ongoing); "Asthma" (unspecified if ongoing); "Obesity" (unspecified if ongoing); "Hypothyroid" (unspecified if ongoing), notes: Hypothyroid; "Lichen sclerosus" (unspecified if ongoing); "Known allergies: Sulfa" (unspecified if ongoing). Concomitant medication(s) included: LEVOTHYROXIN; LOSARTAN POTASSIUM; METFORMIN. Vaccination history included: BNT162b2 (Dose Number: 1, Batch/Lot No: EN6205, Location of injection: Arm Left), administration date: 12Mar2021, when the patient was 68-year-old, for COVID-19 immunization; BNT162b2 (Dose Number: 2, Batch/Lot No: EN6204, Location of injection: Arm Left), administration date: 05Apr2021, when the patient was 68-year-old, for COVID-19 immunization. The following information was reported: PAIN (non-serious) with onset 28Jan2022, outcome "recovered" (2022), described as "could not lift or stretch it without pain for 2 + months"; PAIN IN EXTREMITY (non-serious) with onset 28Jan2022, outcome "recovered" (2022), described as "left arm was really sore". Therapeutic measures were not taken as a result of pain in extremity, pain.  Additional information: The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within 2 weeks of vaccination.  No follow-up attempts are possible. No further information is expected.
Painful bumps on the right arm around the Injection site, pops up every few months. It goes away  for a while when customer squeezes  out the bumps. It keeps come back. Customer thinks these is due to vaccine administration.
Information was received from a nurse regarding a 6 year old male patient who was vaccinated with a first dose of VAQTA on 29-JAN-2009 (Lot number not reported). The patient was vaccinated with a second dose of VAQTA on 16-JUL-2009 which was 11 days early. No adverse effects were reported. No further information is expected as the nurse declined to provide contact information for follow up.
This spontaneous report as received from a healthcare worker refers to unspecified patients of unknown age and gender. No medical history and concurrent conditions were reported. On an unknown date approximately in 2016 (also reported as unspecified dates since 01-FEB-2016) the patient was vaccinated with VAQTA (lot # L023232, expiry date 25-FEB-2015) (Lot # L023936, expiry date 15-MAR-2017) (dosing regimen and frequency unknown). No concomitant medications were reported. It was reported that the vaccines were exposed to a temperature of 33.4 degrees farenheit for 2 hours and 51.4 degrees farenheit for 1.5 hours. No adverse effects were reported. It was reported that the vaccines that underwent temperature excursion were administered. It was reported that there was no previous temperature excursion. It was also reported that this case was being reported due to a data logger. This case is linked to case numbers 1603USA007489, 1603USA007490, 1603USA007491 via same reporter link. Additional information has been requested.
upper stomach pain; chills; vomiting all night and diarrhea; vomiting all night; severe back ache; This is a spontaneous report from a contactable consumer (patient). A 42-year-old female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number: ER8730), via an unspecified route of administration, administered in the left arm on 01Apr2021 at 12:00 as a single dose for COVID-19 immunization.  Medical history included colitis from an unknown date and unknown if ongoing. Concomitant medication included mesalamine (manufacturer unknown) taken for an unspecified indication, start and stop date were not reported. The patient did not receive other vaccines in four weeks. The patient was tested for COVID-19 with a nasal swab on 04Apr2021 with a result of negative. On 01Apr2021 at 06:00 PM, the patient started to have severe back ache. The patient took Aleve and it didn't go away. The patient then had dinner and took Tylenol extra strength and tried to sleep. The patient took Benadryl to go to sleep as the pain was unbearable. The next day, 02Apr2021, the patient was fine until 09:30 PM. The unbearable backpain came back and the patient also had upper stomach pain. The patient had chills, no fever, vomiting all night and diarrhea. The pain never went away. By Sunday, 04Apr2021, the patient went to the hospital in the emergency room and her gallbladder was removed. The patient was hospitalized on 04Apr2021, for two days, due to the events. The outcome of the events was recovering.
suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included COVID-19 VACCINE (COVID 19 VACCINE (MANUFACTURER UNKNOWN)) for covid-19 prophylaxis.   On an unknown date, the patient received Shingles vaccine and COVID 19 VACCINE (MANUFACTURER UNKNOWN). On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient had vaccination for shingles and got Covid shot and 4 weeks got shingles. It was unknown if the reporter considered the shingles to be related to Covid-19 vaccine. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming herpes zoster were unknown at the time of reporting.
Tdap given on 2-9-2020. Patient noted HA & nausea on 2-10-2020 & continous symptoms till today (2-23-2020), no other symptoms.
After 4 hours of  1st injection started to feel heat and swelling of face.  In the morning woke up to red swollen cheeks and eyes.  Itching sporadic over entire body.   Eczema that was dormant flared on legs and upper arms.   Severe headache which did not respond to Tylenol.
Patient administered Moderna booster dose 2 weeks early.  No treatment.  Moderna vaccination dates 1st dose 04/09/2021 and 2nd dose 07/06/2021. Booster dose was administered 12/23/2021, 14 days too soon.
Pfizer-BioNTech COVID-19 Vaccine:  1/4/21 Started with dull ache pain to left upper tooth, worsened with chewing and eating on left side on day one. Symptoms became worse during the day with electric like pain radiating to the maxilla, TMJ and temple. Symptoms persisted as episodic aching and electrical radicular pain 1/5 so I saw my dentist in the afternoon with a negative work up on exam and xray. Pain worsened and pattern expanded to include pain under tongue on left side. There are times there is no pain and then the pain will come on without known cause, but anytime with eating or chewing the pain starts and is exacerbated. Also impacted by hot items/drinks.  I have tried ibuprofen and tylenol sinus medications without impact on episodic flares of pain.
Patient received 5 shots at routine well child visit on 10/27/05. She was fussy the rest of the day and slept all day on the 25th awakening only to eat, The mother treated the child with Tylenol cold drops for infants. 2/23/06 Received medical records from PCP.  2/23/06 Received Autopsy Report which states COD is Acute bronchopneumonia./ss
No additional AE reported; HCP reporting VAQTA, PEDVAXHIB, and ROTATEQ were administered after a temperature excursion. Caller stated she did not have the exact dates of administration nor the names of the patients involved. No additional information provided. No additional AE; This spontaneous report was received from a Health Care Professional and refers to a 4-month-old female patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported.  On 14-DEC-2022, the patient was vaccinated with the second dose of Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAXHIB) intramuscular injection, in left thigh, lot #W006596, expiration date: 11-OCT-2024, administered intramuscularly for prophylaxis (strength was not provided), and with Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ)  lot #1892784, expiration date: 03-DEC-2023, administered orally for prophylaxis (strength was not provided).   The administered dose of the vaccine experienced a temperature excursion (product storage error) since 01-DEC-2022. The vaccine administered were stored at temperatures excursion of 47.9 Fahrenheit (storage in clinical practice) for 47 minutes. Data logger was involved. No adverse event was reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2301USA001175: US-009507513-2301USA009088: US-009507513-2301USA009024: US-009507513-2301USA009110: US-009507513-2301USA009878: US-009507513-2301USA009896:
Pt reported to the Health Unit 45 min after injection with left arm pain, radiating to hand; hand tingling, skin very sensitive to touch. Mild swelling at site with no redness. Treatment: IM Depo-Medrol 40 mg also to left deltoid. Then Motrin three times a day as needed.
Rash, swelling, and redness starting at least 4 inches below injection site, with fairly clear puncture marks resembling a spider bite. Nevertheless, the urgent care gave cephalexin.
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. On an unknown date the patients were vaccinated with a doses of improperly stored of GARDASIL (lot number, strength, dose and route were not reported). No adverse effects were reported. The outcome of the patients event was not reported. This is one of several reports from the same source. Additional information has been requested.
arm hurt a little; Small fever for couple of days,worse at night; Felt tired and slightly sick; water leaking down my arm; after squeezing the arm of the injection, more water began to leak and a small amount of blood, bleed water; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE HAEMORRHAGE (after squeezing the arm of the injection, more water began to leak and a small amount of blood, bleed water), PAIN IN EXTREMITY (arm hurt a little), VACCINATION SITE DISCHARGE (water leaking down my arm), PYREXIA (Small fever for couple of days,worse at night) and FATIGUE (Felt tired and slightly sick) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048b21a and 025b21a) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concurrent medical conditions included Ear ringing (More louder ear fullness and bilateral ringing Jul 2021.Still undiagnosed, dr shortage.) since 2021. Concomitant products included PARACETAMOL (TYLENOL) and ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.   On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Apr-2021, the patient experienced VACCINATION SITE HAEMORRHAGE (after squeezing the arm of the injection, more water began to leak and a small amount of blood, bleed water) and VACCINATION SITE DISCHARGE (water leaking down my arm). On 01-May-2021, the patient experienced PYREXIA (Small fever for couple of days,worse at night) and FATIGUE (Felt tired and slightly sick). On an unknown date, the patient experienced PAIN IN EXTREMITY (arm hurt a little). On 03-May-2021, PYREXIA (Small fever for couple of days,worse at night) had resolved. On 04-May-2021, FATIGUE (Felt tired and slightly sick) had resolved. At the time of the report, VACCINATION SITE HAEMORRHAGE (after squeezing the arm of the injection, more water began to leak and a small amount of blood, bleed water), PAIN IN EXTREMITY (arm hurt a little) and VACCINATION SITE DISCHARGE (water leaking down my arm) outcome was unknown.             No treatment medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 02-Jun-2021: Follow up received - Updated reporter details, updated patient demographics, added events pyrexia, pain in extremities, fatigue and malaise and updated information about facility where vaccine was given On 22-Jul-2021: Follow up received -Vaccine Facility information updated ,Lot/Batch number added, and added chronic condition.
Under 18years patient received Moderna COVID-19 vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Under 18years patient received Moderna COVID-19 vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Under 18years patient received Moderna COVID-19 vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Under 18years patient received Moderna COVID-19 vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Reporter did not allow further contact
Itching on neck, arms, face, ears, chest-burning. then tongue, throat itching client treated self with 25ml of Atarax saw improvement after 10 minutes; left on own accord.
Pt reported severe throbbing pain upon injection. It was treated hours later with hydrocodone/APAP 5-325.  Pt reported pain upon any movement of arm the next day.
MUSCLE SORENESS IN LEFT ARM FROM INJECTION SITE AND DISTALLY TO MID-FOREARM WHEN ARM IS RAISED FROM THE SIDE(ABDUCTION) AND WHEN IT'S MOVED ACROSS BODY TO HER RIGHT SIDE
I contracted COVID-19 on 06/13/2022 with symptoms of severe cough, body aches, shortness of breathe, chest tightness, and fatigue. I was prescribed Paxlovid, Prednisone, Promethazine; Ivermectin, and Azithromycin, on 06/13/2022. I was ill for 10 to 14 days before my symptoms began to resolve. I am still experiencing lingering symptoms of fatigue, shortness of breathe, and chest tightness. For the last 3 weeks I have been having IV infusions of vitamins and steroids prescribed by my doctor.
RASH TO TORSO ,FACE, NOTICED SOME EDEMA AROUND EYES ON 4/26 PM NO PROBLEMS WITH BREATHING OR SWALLOWING. WENT TO URGENT CARE AT 8 PM- NO LABS PERFORMS. GIVEN ORAL BENADRYL
Information has been received from a Registered Nurse and a physician concerning a 15 year old female patient who on 17-MAR-2010 was vaccinated intramuscularly with the first 0.5 ml dose of GARDASIL. Subsequently the patient developed a rash on her body. The rash was itchy and red. On an unspecified date, the patient recovered. The patient sought medical attention (office visit). Follow up information has been received from a Registered Nurse who reported that the 15 year old female patient with asthma and no illness at the time of vaccination, was vaccinated intramuscularly in the right deltoid with the first dose of GARDASIL (lot # 662529/1317Y) on 17-MAR-2010 at 18:00. Concomitant therapy included ALLEGRA-D, montelukast sodium (MSD), NASACORT and albuterol. It was stated that 10 days after administration, on 21-MAR-2010, the patient reported by a phone conversation that shortly after GARDASIL administration, on approximately 18-MAR-2010, she developed a pinpoint red "heat rash" over trunk. On 29-MAR-2010, on exam, rash was resolving. The patient was diagnosed with dermatitis unspecified. The patient also described a "lump" at the site, which was presumed to be a local reaction which resolved on an unspecified date. No laboratory diagnostic studies were performed. No further information is available.
reports swelling L arm and axilla, redness down L arm with increased warmth, itching, and pain in L arm
Muscle pain, site pain, gradually spreading up neck and down arm, no initial redness, dime size welt after 36 hours, half dollar size welt after 48+ hours, fatigue, nausea, left ear pain, dizziness, joint pain initial 36 hours, headache began initial 24 hours, temp (ear) 99.3 initial 24 hours. Tylenol, rest, time off work.
After receiving 2nd dose patient never got menstrual cycle; Arm soreness / Left arm pain; Feeling sick; Muscle pain, body aches; Red bump at injection site; Red bump at injection site; Small rash at injection site; Severe fatigue; This spontaneous case was reported by a consumer and describes the occurrence of MENSTRUAL DISORDER (After receiving 2nd dose patient never got menstrual cycle), PAIN IN EXTREMITY (Arm soreness / Left arm pain), VACCINATION COMPLICATION (Feeling sick), MYALGIA (Muscle pain, body aches) and VACCINATION SITE SWELLING (Red bump at injection site) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021B21A and 027A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Cramps and Bleeding. Concomitant products included MULTIVITAMINS [VITAMINS NOS] for an unknown indication.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Apr-2021, the patient experienced MENSTRUAL DISORDER (After receiving 2nd dose patient never got menstrual cycle), PAIN IN EXTREMITY (Arm soreness / Left arm pain), VACCINATION COMPLICATION (Feeling sick), MYALGIA (Muscle pain, body aches), VACCINATION SITE SWELLING (Red bump at injection site), VACCINATION SITE ERYTHEMA (Red bump at injection site), VACCINATION SITE RASH (Small rash at injection site) and FATIGUE (Severe fatigue). On 07-Apr-2021, VACCINATION COMPLICATION (Feeling sick), MYALGIA (Muscle pain, body aches) and FATIGUE (Severe fatigue) had resolved. On 08-Apr-2021, PAIN IN EXTREMITY (Arm soreness / Left arm pain), VACCINATION SITE SWELLING (Red bump at injection site), VACCINATION SITE ERYTHEMA (Red bump at injection site) and VACCINATION SITE RASH (Small rash at injection site) had resolved. At the time of the report, MENSTRUAL DISORDER (After receiving 2nd dose patient never got menstrual cycle) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Pregnancy test: negative.         The patient reported that she never got menstrual cycle after the first dose and was due for her menstrual cycle the day after the first dose was given. The patient stated that her cycle was very regular and never got period in the month of ??-Mar-2021. She felt cramps and had bleeding before receiving second dose on 05-Apr-2021. After receiving second dose patient never got menstrual cycle though had her typical before her period symptoms. The patient was concerned and wanted to report this side effect and planned to notify her healthcare provider. The patient had taken numerous pregnancy tests after both doses and since she has had no menstrual period since prior to 05-Mar-2021 and all pregnancy tests were negative. The patient confirmed and reiterated that she was not pregnant.   This case was linked to MOD-2021-089443 (Patient Link).